Health Canada's Therapeutic Products Directorate has granted manufacturing and marketing approval for tamsulosin 0.4mg capsules [Ranbaxy Laboratories].

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1616, 2007-01, pp. : 27-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ranbaxy has voluntarily recalled all lots of nitrofurantoin (monohydrate/macrocrystals) 100mg capsules from the US market

By  

Reactions Weekly, Vol. 1, Iss. 1251, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Generic amlodipine granted marketing approval in Japan.

By  

Inpharma, Vol. 1, Iss. 1634, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Health Canada has issued a Qualifying Notice for the approval of dronabinol/cannabidiol

By  

Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Health Canada has granted a notice of compliance for Bristol-Myers Squibb's dasatinib [Sprycel] for use in patients with chronic myeloid leukaemia

By  

Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

The WHO has added another four antiretrovirals from Ranbaxy Laboratories to its prequalification list

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 505, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite